Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05291936 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of Two Daily Disposable Toric Soft Contact Lenses Over One Week of Wear
A NA study of Ocular Physiology, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 78
- Enrollment target
- 5
- Study locations
NCT05291936 is a NA study of Ocular Physiology that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 78 participants. The trial reports 5 study locations across 4 states.
The verdict
NCT05291936, a NA study of Ocular Physiology, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 78 participants
- Enrollment target
- 5
- Study locations
Study Summary
This is a bilateral wear, dispensing, randomized, controlled, double-masked, 2-sequence ×2-period crossover study to evaluate ocular physiology following contact lens wear.
Conditions Studied
Interventions
- DEVICE PRECISION1® for Astigmatism Contact Lenses
- DEVICE MyDay® Toric Soft Contact Lenses
Study Locations (5)
Florida
- VRC - Jacksonville
- Sabal Eye Care - Longwood
New York
- Sacco Eye Group - Vestal
Ohio
- Professional Vision Care Inc. - Westerville - Westerville
Virginia
- Botetourt Eyecare LLC - Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2022-03-30 |
| Est. Completion | 2022-05-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05291936
The ClinicalTrials.gov registry entry for NCT05291936 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Ocular Physiology appearing as the primary indexed condition, and to 2 interventions - of which PRECISION1® for Astigmatism Contact Lenses is the first listed.
NCT05291936 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Florida, New York, Ohio.
Frequently Asked Questions
What is clinical trial NCT05291936 about?
NCT05291936 is a clinical study titled "Clinical Evaluation of Two Daily Disposable Toric Soft Contact Lenses Over One Week of Wear". This is a bilateral wear, dispensing, randomized, controlled, double-masked, 2-sequence ×2-period crossover study to evaluate ocular physiology following contact lens wear.
What is the current status of trial NCT05291936?
This trial is currently completed. It is a NA study. The enrollment target is 78 participants. The study started on 2022-03-30. Estimated completion is 2022-05-27.
What conditions does trial NCT05291936 study?
This clinical trial studies the following conditions: Ocular Physiology.
What interventions are being tested in trial NCT05291936?
The interventions under investigation include: PRECISION1® for Astigmatism Contact Lenses (DEVICE), MyDay® Toric Soft Contact Lenses (DEVICE).
Who is sponsoring clinical trial NCT05291936?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05291936 being conducted?
This trial has 5 study locations across Florida, New York, Ohio, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ocular Physiology
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.